m+Medelevator.RU
← Поиск публикаций
Carbohydrate polymers · 2025

Delivery of penetration-enhancing antioxidant polyphenol nanoparticles with Codonopsis pilosula polysaccharide microneedles for synergistic treatment of psoriasis.

СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Liu Siqi, Song Silu, Zhang Yu, Yan Liming, Chen Yuhui, Li Wanrong, Jalil Banaz, Wu Chun, Fu Yuping, Chen Xingfu, Gu Jingyi, Li Lixia, Yin Zhongqiong, Song Xu, Tian Mengliang, Zou Yuanfeng

Аннотация

Poor drug penetration due to local skin thickening and microenvironmental redox imbalance remain a critical challenge in the treatment of epidermal diseases. Considering that oxidative stress due to the overproduction of Reactive Oxygen Species (ROS) in the skin microenvironment is one of the main mechanisms in the pathogenesis of psoriasis, we developed a ROS-sensitive transdermal drug delivery system to enhance topical treatment of psoriasis. Cross-linked cyclodextrin metal-organic framework (COF) containing curcumin (CUR) was dispersed in two types of dissolving polysaccharide microneedles (CPPAP-MNs-CUR@COF, CPPNP-MNs-CUR@COF) made from Codonopsis pilosula neutral polysaccharides (CPPNP) and acidic polysaccharides (CPPAP) for topical administration. COF contains peroxyoxalate bonds that scavenge H2O2, hydrolyse and eliminate ROS generated at the site of inflammation. Microneedles (MNs) that break through the skin's physical barrier improve drug penetration, while Codonopsis pilosula Polysaccharides (CPP) can synergise with CUR to significantly attenuate inflammation and oxidative stress and ameliorate imiquimod (IMQ)-induced symptoms of psoriasis in mice through inhibition of the IL-23/IL-17 inflammatory axis. It is a promising drug delivery system that is expected to provide new strategies for the topical treatment of psoriasis in the clinical setting.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты